Analyst
J.P. Morgan
Equibles does not estimate personal net worth.
Lily is recorded as Analyst at J.P. Morgan. Lily has spoken on 4 earnings calls across 3 companies, most recently for Enovis CORP on August 6, 2026. Those appearances were for Ceribell, Inc. (CBLL), Enovis CORP (ENOV) and iRhythm Holdings, Inc. (IRTC). The companies whose calls Lily spoke on are classified in the Healthcare sector.
“And following up on the question around macro trends, on the general market and procedure backdrop, we've heard some different commentary from some of your peers around the health of the ortho market in the second quarter.”
“I just wanted to ask about Q1 and the guidance. you know, Q1 came in a little better than the street, and you raised the guide by 1 million, a little bit more than the beat.”
“As we think about 2026, can you talk through what you see as the main levers of growth that you're pulling this year? I know you talked about accelerating account ads.”
“You obviously ended the year on a high note, really good momentum exiting 2024. So I was hoping you could just share a bit of color on how that momentum has continued into 2025 so far and some of the trends that you've been seeing so far in the first quarter.”
J.P. Morgan
Analyst
Transcript header (unverified)
CBLL
Medical Devices · Healthcare
ENOV
Medical Devices · Healthcare
